SCHEMBL8314813

SCHEMBL8314813

O=C(c1ccc(Nc2nccc(-c3ccc(S(=O)(=O)c4ccccc4)cc3)n2)cc1)N1CCN(C(=O)c2ccco2)CC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTOR P42345 1/20 0.54
SMG1 Q96Q15 1/20 0.54
ALDH1A1 P00352 4/20 0.53
LMNA P02545 4/20 0.53
TSHR P16473 2/20 0.53
NPSR1 Q6W5P4 1/20 0.53
CA12 O43570 1/20 0.51
CA1 P00915 1/20 0.51
CA2 P00918 1/20 0.51
CA7 P43166 1/20 0.51
CA9 Q16790 1/20 0.51
SMN1; SMN2 Q16637 3/20 0.51
HTT P42858 2/20 0.51
IKBKB O14920 7/20 0.50
CAMK2D Q13557 2/20 0.50
CHUK O15111 4/20 0.49
IKBKG Q9Y6K9 1/20 0.49
MAPK8 P45983 1/20 0.48
MAPK10 P53779 1/20 0.48
TP53 P04637 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8312956 0.94 TSHR (0.54) MTORSMG1ALDH1A1LMNATSHR
SCHEMBL14021335 0.88 MTOR (0.51) MTORSMG1ALDH1A1LMNATSHR
SCHEMBL14020977 0.88 JAK2 (0.58) MTORSMG1IKBKBCAMK2DCHUK
SCHEMBL8314825 0.88 MTOR (0.57) MTORSMG1LMNAIKBKBCAMK2D
SCHEMBL8314809 0.88 MTOR (0.57) MTORSMG1IKBKBCAMK2DCHUK
SCHEMBL4071019 0.87 IKBKB (0.56) TSHRIKBKBCHUKMAPK8MAPK10
SCHEMBL14021618 0.87 HTT (0.54) ALDH1A1LMNATSHRNPSR1HTT
SCHEMBL14021252 0.87 ALDH1A1 (0.62) ALDH1A1LMNATSHRNPSR1SMN1; SMN2
SCHEMBL14063912 0.86 IKBKB (0.64) MTORSMG1IKBKBCAMK2DCHUK
SCHEMBL8312206 0.85 MTOR (0.50) MTORSMG1ALDH1A1LMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7442699-B2 Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto SIGNAL PHARMACEUTICALS, LLC (US) 2008-10-28 US disclosed
US-7442699-B2 Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto SIGNAL PHARMACEUTICALS, LLC (US) 2008-10-28 US disclosed
US-7429599-B2 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK SIGNAL PHARMACEUTICALS, LLC (US) 2008-09-30 US disclosed
US-7429599-B2 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK SIGNAL PHARMACEUTICALS, LLC (US) 2008-09-30 US disclosed
WO-2004084901-A1 METHODS FOR TREATING OR PREVENTING AN INFLAMMATORY OR METABOLIC CONDITION BY INHIBITING JNK SIGNAL PHARMACEUTICALS, LLC (US) 2004-10-07 WO disclosed